BFAD encourages public to buy medicines from drugstores
by Lito Dar
Baguio City (17 October) -- In line with the theme of Consumer Welfare Month, " Generic Drugs: Gawang Pinoy! Galing Pinoy! Tangkilikin Natin!", the Bureau of Food and Drugs (BFAD) is encouraging the public to buy medicines from licensed drugstores while batting for the establishment of a botika ng barangay in every community.
This year, the Department of Health is spearheading the celebration, in support of the Cheaper Medicines Act and in line with the government t thrust to assure the availability of affordable and quality drugs and medicines to the public.
In line with this, CONSUMERNET, an alliance of government line agencies supporting consumer rights, is conducting information and education activities on consumer welfare through various forums and radio/TV programs.
In a radio interview Tuesday, DOH-CAR Regulation Officer II Lilly Ann Aglubat stressed that in line with government's thrust to assure the availability of safe, effective and affordable medicines for everyone, the health department is advocating for the establishment's of at least one "Botika ng Barangay," in every community especially in the far flung areas.
In connection to this, Aglubat is appealing on sari-sari store owners not to sell medicines, especially those that are classified as prescription drugs, for the safety of everyone.
Aglubat explained that selling medicines or drugs is not included on the permit of establishing a "sari-sari" store. Thus consumers should buy their medicines from licensed drugstores or establishment.
"Drugstores have licensed pharmacist, wherein the buying public or consumers, can even avail or ask for information regarding the medicines they are buying," Aglubat said as she encouraged store owners to put up an organization to establish a "Botika ng Barangay" in their locality.
Aglubat also assured the public that there is no shortage in medicines and that there is no price increase in medicine. She assured that they are continuously monitoring the price of medicines not only due to the typhoons, but also in connection with the recent Maximum Drug Retail Price (MDRP) and Mediated Access Price on some specified medicines. (PIA) [top]